Search results
Lexaria Bioscience (NASDAQ: LEXX) Hires CRO; Set for First Tirzepatide Molecule Study
Digital Journal· 13 hours agoPRESS RELEASE Published June 17, 2024 InvestorBrandNetwork Lexaria, a global innovator in drug delivery platforms, recently announced the hiring of a Contract Research ...
Lokavant introduces AI-powered feasibility software designed to optimise trials
Clinical Trials Arena via Yahoo Finance· 6 days agoUS-based clinical trial software company Lokavant has launched Spectrum, a feasibility software...
Axiom Real-Time Metrics Announces Leadership Transition
Morningstar· 5 days agoAxiom Real-Time Metrics Announces Leadership Transition Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services that are used to enhance the efficiency of Phase I, II and III clinical trials and observational
Lokavant launches AI solution for real-time clinical trial optimization
FierceBiotech· 6 days agoLokavant has released a new artificial intelligence solution it claims can help contract research ...
James S. Hanson Buys 2,000 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) Stock
ETF DAILY NEWS· 5 days agoHanson bought 2,000 shares of the stock in a transaction on Wednesday, June 12th. The shares were bought at an average price of $25.30 per share, for a total transaction of $50,600.00. Following ...
Baird cuts IQVIA Holdings shares target on neutral outlook By Investing.com
Investing.com· 5 days agoThe revision follows a detailed valuation analysis by Baird, which included various financial...
Think Research Announces Sale of BioPharma Services
Digital Journal· 5 days agoBioPharma is a leading contract research organization (CRO) specializing in Phase 1 clinical trials, and was initially acquired by Think ...
WuXi Biologics Jumps on Hope Key US Sanction Bill May Hit Wall
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Shares in WuXi Biologics Cayman Inc. surged the most in 19 months on speculation a US...
Medpace Holdings (MEDP) Continues to Deliver Robust Financial Results
Insider Monkey via Yahoo Finance· 6 days agoWasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth...
Hemogenyx Pharmaceuticals PLC Announces Operations Update
Digital Journal· 23 hours agoOperations Update LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its
